Ionizing radiation biomarkers for potential use in epidemiological studies

Mutation Research - Reviews in Mutation Research

Volumn 751, Issue 2, 2012, Pages 258-286

  Pernot, Eileen ^a   Hall, Janet ^b   Baatout, Sarah ^c,m   Benotmane, Mohammed Abderrafi ^c   Blanchardon, Eric ^d   Bouffler, Simon ^e   El Saghire, Houssein ^c,m   Gomolka, Maria ^f   Guertler, Anne ^f   Harms Ringdahl, Mats ^g   Jeggo, Penny ^h   Kreuzer, Michaela ^f   Laurier, Dominique ^d   Lindholm, Carita ⁱ   Mkacher, Radhia ^j   Quintens, Roel ^c   Rothkamm, Kai ^e   Sabatier, Laure ^j   Tapio, Soile ^k   de Vathaire, Florent ^l   Cardis, Elisabeth ^a   more..

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b INSERM U612   (France)

^c BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^g STOCKHOLM UNIVERSITY   (Sweden)

^h UNIVERSITY OF SUSSEX   (United Kingdom)

ⁱ STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^j INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

^l INSERM   (France)

^m GHENT UNIVERSITY   (Belgium)

more..

Author keywords

Biomarkers; DoReMi; Low dose ionizing radiation; MELODI; Molecular epidemiology

Indexed keywords

AMYLASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARCINOGEN; CYTOKINE; FLT3 LIGAND; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICRORNA; PHOSPHOPROTEIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BIOLOGY; CELL CYCLE; CELL SURVIVAL; CYTOGENETICS; DICENTRIC CHROMOSOME; DNA METHYLATION; DNA STRAND BREAKAGE; DOSIMETRY; EPIDEMIOLOGICAL DATA; EPIGENETICS; GENE MUTATION; HEALTH HAZARD; HISTONE MODIFICATION; HUMAN; IONIZING RADIATION; METABOLITE; METABOLOMICS; MICRONUCLEUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PREMATURE CHROMOSOME CONDENSATION; PRIORITY JOURNAL; PROTEOMICS; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

BIOLOGICAL MARKERS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DNA DAMAGE; EPIDEMIOLOGIC STUDIES; EPIGENESIS, GENETIC; HUMANS; METABOLOMICS; MOLECULAR EPIDEMIOLOGY; RADIATION, IONIZING; REACTIVE OXYGEN SPECIES;

EID: 84865634846     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2012.05.003     Document Type: Review

References (264)

1. Scientific Committee on the Effects of Atomic Radiation, UNSCEAR, Effects of Ionising Radiation, Volume I, United Nations, 2006.
2. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007, 168:1-64.
3. Preston D.L., Pierce D.A., Shimizu Y., Cullings H.M., Fujita S., Funamoto S., et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 2004, 162:377-389.
4. Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C., et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat. Res. 2007, 167:396-416.
5. Muirhead C.R., O'Hagan J.A., Haylock R.G.E., Phillipson M.A., Willcock T., Berridge G.L.C., et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer 2009, 100:206-212.
6. Doll R., Wakeford R. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 1997, 70:130-139.
7. Mullenders L., Atkinson M., Paretzke H., Sabatier L., Bouffler S. Assessing cancer risks of low-dose radiation. Nat. Rev. Cancer 2009, 9:596-604.
8. Twardella D., Chang-Claude J. Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. Radiother. Oncol. 2002, 62:249-260.
9. Nakachi K., Hayashi T., Imai K., Kusunoki Y. Perspectives on cancer immuno-epidemiology. Cancer Sci. 2004, 95:921-929.
10. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 2000, 92:874-897.
11. WHO, Biomarkers and risk assessment: concepts and principles (EHC 155, 1993), (n.d.).
12. Grandjean P. Biomarkers in epidemiology. Clin. Chem. 1995, 41:1800-1803.
13. Committee on Biological Markers of the National Research Council Biological markers in environmental health research. Environ. Health Perspect. 1987, 74:3-9.
14. Schulte P., Mazzuckelli L.F. Validation of biological markers for quantitative risk assessment. Environ. Health Perspect. 1991, 90:239-246.
15. Collins A.R. Molecular epidemiology in cancer research. Mol. Aspects Med. 1998, 19:359-432.
16. Perera F.P., Weinstein I.B. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000, 21:517-524.
17. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95.
18. Bonassi S., Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 2002, 511:73-86.
19. Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004, 1:182-188.
20. Cebulska-Wasilewska A. Response to challenging dose of X-rays as a predictive assay for molecular epidemiology. Mutat. Res. 2003, 544:289-297.
21. P. Maruvada, W. Wang, P.D. Wagner, S. Srivastava, Biomarkers in molecular medicine: cancer detection and diagnosis, BioTechniques (Suppl) (2005) 9-15.
22. Ryan P.B., Burke T.A., Cohen Hubal E.A., Cura J.J., McKone T.E. Using biomarkers to inform cumulative risk assessment. Environ. Health Perspect. 2007, 115:833-840.
23. Hande M.P., Azizova T.V., Burak L.E., Khokhryakov V.F., Geard C.R., Brenner D.J. Complex chromosome aberrations persist in individuals many years after occupational exposure to densely ionizing radiation: an mFISH study. Genes Chromosom. Cancer 2005, 44:1-9.
24. Decordier I., Loock K.V., Kirsch-Volders M. Phenotyping for DNA repair capacity. Mutat. Res. 2010, 705:107-129.
25. Knudsen L.E., Hansen A.M. Biomarkers of intermediate endpoints in environmental and occupational health. Int. J. Hyg. Environ. Health 2007, 210:461-470.
26. Strimbu K., Tavel J.A. What are biomarkers?. Curr. Opin. HIV AIDS 2010, 5:463-466.
27. Rothman K.J., Greenland S., Lash T.L. Modern Epidemiology 2008, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
28. Cardis E., Kesminiene A., Ivanov V., Malakhova I., Shibata Y., Khrouch V., et al. Risk of thyroid cancer after exposure to 131I in childhood. J. Natl. Cancer Inst. 2005, 97:724-732.
29. IAEA, Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergencies, 2011.
30. García-Closas M., Egan K.M., Abruzzo J., Newcomb P.A., Titus-Ernstoff L., Franklin T., et al. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol. Biomarkers Prev. 2001, 10:687-696.
31. Hansen T.V.O., Simonsen M.K., Nielsen F.C., Hundrup Y.A. Collection of blood, saliva, and buccal cell samples in a pilot study on the Danish nurse cohort: comparison of the response rate and quality of genomic DNA. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2072-2076.
32. Rogers N.L., Cole S.A., Lan H.-C., Crossa A., Demerath E.W. New saliva DNA collection method compared to buccal cell collection techniques for epidemiological studies. Am. J. Hum. Biol. 2007, 19:319-326.
33. Ambrosone C.B., Ciupak G.L., Bandera E.V., Jandorf L., Bovbjerg D.H., Zirpoli G., et al. Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women. J. Oncol. 2009, 2009:871250.
34. Nishita D.M., Jack L.M., McElroy M., McClure J.B., Richards J., Swan G.E., et al. Clinical trial participant characteristics and saliva and DNA metrics. BMC Med. Res. Methodol. 2009, 9:71.
35. Patel R.S., Jakymiw A., Yao B., Pauley B.A., Carcamo W.C., Katz J., et al. High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 2011.
36. Rylander-Rudqvist T., Håkansson N., Tybring G., Wolk A. Quality and quantity of saliva DNA obtained from the self-administrated oragene method-a pilot study on the cohort of Swedish men. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1742-1745.
37. Støy J., Greeley S.A.W., Paz V.P., Ye H., Pastore A.N., Skowron K.B., et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr. Diabetes 2008, 9:450-459.
38. Holland N.T., Smith M.T., Eskenazi B., Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat. Res. 2003, 543:217-234.
39. Spits C., Le Caignec C., De Rycke M., Van Haute L., Van Steirteghem A., Liebaers I., et al. Whole-genome multiple displacement amplification from single cells. Nat. Protoc. 2006, 1:1965-1970.
40. Paliwal A., Vaissière T., Herceg Z. Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids. Methods 2010, 52:242-247.
41. Vähäkangas K. Ethical aspects of molecular epidemiology of cancer. Carcinogenesis 2004, 25:465-471.
42. WMA, Declaration on Ethical Considerations regarding Health Databases, 2002.
43. Deutscher nationaler Ethikrat, Humanbiobanken für die Forschung, Berlin, 2010.
44. WMA, Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects, 2008.
45. Elger B.S., Caplan A.L. Consent and anonymization in research involving biobanks: differing terms and norms present serious barriers to an international framework. EMBO Rep. 2006, 7:661-666.
46. Salvaterra E., Lecchi L., Giovanelli S., Butti B., Bardella M.T., Bertazzi P.A., et al. Banking together. A unified model of informed consent for biobanking. EMBO Rep. 2008, 9:307-313.
47. Goodarzi A.A., Jeggo P.A. Irradiation induced foci (IRIF) as a biomarker for radiosensitivity. Mutat. Res. 2011.
48. Hu Z.-Z., Huang H., Wu C.H., Jung M., Dritschilo A., Riegel A.T., et al. Omics-based molecular target and biomarker identification. Methods Mol. Biol. 2011, 719:547-571.
49. Dossou J., Lartigau E., M'Kacher R., Légal J.D., Bridier A., Guichard M., et al. Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:123-129.
50. Cornforth M.N. Analyzing radiation-induced complex chromosome rearrangements by combinatorial painting. Radiat. Res. 2001, 155:643-659.
51. Edwards A.A., Lindholm C., Darroudi F., Stephan G., Romm H., Barquinero J., et al. Review of translocations detected by FISH for retrospective biological dosimetry applications. Radiat. Prot. Dosimetry 2005, 113:396-402.
52. Sigurdson A.J., Ha M., Hauptmann M., Bhatti P., Sram R.J., Beskid O., et al. International study of factors affecting human chromosome translocations. Mutat. Res. 2008, 652:112-121.
53. Tucker J.D. Low-dose ionizing radiation and chromosome translocations: a review of the major considerations for human biological dosimetry. Mutat. Res. 2008, 659:211-220.
54. Tucker J.D., Luckinbill L.S. Estimating the lowest detectable dose of ionizing radiation by FISH whole-chromosome painting. Radiat. Res. 2011, 175:631-637.
55. Furukawa A., Minamihisamatsu M., Hayata I. Low-cost metaphase finder system. Health Phys. 2010, 98:269-275.
56. Savage J.R., Simpson P.J. FISH 'painting' patterns resulting from complex exchanges. Mutat. Res. 1994, 312:51-60.
57. Anderson R.M., Marsden S.J., Paice S.J., Bristow A.E., Kadhim M.A., Griffin C.S., et al. Transmissible and nontransmissible complex chromosome aberrations characterized by three-color and mFISH define a biomarker of exposure to high-LET alpha particles. Radiat. Res. 2003, 159:40-48.
58. Hada M., Wu H., Cucinotta F.A. mBAND analysis for high- and low-LET radiation-induced chromosome aberrations: a review. Mutat. Res. 2011, 711:187-192.
59. Sabatier L., Al Achkar W., Hoffschir F., Luccioni C., Dutrillaux B. Qualitative study of chromosomal lesions induced by neutrons and neon ions in human lymphocytes at G0 phase. Mutat. Res. 1987, 178:91-97.
60. Wahab M.A., Nickless E.M., Najar-M'kacher R., Parmentier C., Podd J.V., Rowland R.E. Elevated chromosome translocation frequencies in New Zealand nuclear test veterans. Cytogenet. Genome Res. 2008, 121:79-87.
61. K. Buckton, Chromosome aberrations in patients treated with X-irradiation for ankylosing spondylitis, in: T. Ishihara, M.S. Sasaki (Eds.), Radiation-induced Chromosome Damage in Man, 1983, pp. 491-511.
62. M'kacher R., Bennaceur-Griscelli A., Girinsky T., Koscielny S., Delhommeau F., Dossou J., et al. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:465-471.
63. Kodama Y., Pawel D., Nakamura N., Preston D., Honda T., Itoh M., et al. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation. Radiat. Res. 2001, 156:337-346.
64. Neel J.V. An association, in adult Japanese, between the occurrence of rogue cells among cultured lymphocytes (JC virus activity) and the frequency of 'simple' chromosomal damage among the lymphocytes of persons exhibiting these rogue cells. Am. J. Hum. Genet. 1998, 63:489-497.
65. Lazutka J.R. Chromosome aberrations and rogue cells in lymphocytes of Chernobyl clean-up workers. Mutat. Res. 1996, 350:315-329.
66. Slozina N., Neronova E., Kharchenko T., Nikiforov A. Increased level of chromosomal aberrations in lymphocytes of Chernobyl liquidators 6-10 years after the accident. Mutat. Res. 1997, 379:121-125.
67. Vorobtsova I.E., Semenov A.V. Complex cytogenetic characteristic of people suffered from Chernobyl accident. Radiats Biol. Radioecol. 2006, 46:140-151.
68. Durante M., Furusawa Y., Gotoh E. A simple method for simultaneous interphase-metaphase chromosome analysis in biodosimetry. Int. J. Radiat. Biol. 1998, 74:457-462.
69. Kanda R., Hayata I., Lloyd D.C. Easy biodosimetry for high-dose radiation exposures using drug-induced, prematurely condensed chromosomes. Int. J. Radiat. Biol. 1999, 75:441-446.
70. Pantelias G.E., Maillie H.D. The use of peripheral blood mononuclear cell prematurely condensed chromosomes for biological dosimetry. Radiat. Res. 1984, 99:140-150.
71. Darroudi F., Natarajan A.T. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6. VII. Complementation analysis of X-irradiated wild-type CHO-K1 and xrs mutant cells using the premature chromosome condensation technique. Mutat. Res. 1989, 213:249-255.
72. Prasanna P.G.S., Blakely W.F. Premature chromosome condensation in human resting peripheral blood lymphocytes for chromosome aberration analysis using specific whole-chromosome DNA hybridization probes. Methods Mol. Biol. 2005, 291:49-57.
73. Lindholm C., Stricklin D., Jaworska A., Koivistoinen A., Paile W., Arvidsson E., et al. Premature chromosome condensation (PCC) assay for dose assessment in mass casualty accidents. Radiat. Res. 2010, 173:71-78.
74. Lamadrid A.I., García O., Delbos M., Voisin P., Roy L. PCC-ring induction in human lymphocytes exposed to gamma and neutron irradiation. J. Radiat. Res. 2007, 48:1-6.
75. Ainsbury E.A., Bakhanova E., Barquinero J.F., Brai M., Chumak V., Correcher V., et al. Review of retrospective dosimetry techniques for external ionising radiation exposures. Radiat. Prot. Dosimetry 2011, 147:573-592.
76. M'kacher R., Violot D., Aubert B., Girinsky T., Dossou J., Béron-Gaillard N., et al. Premature chromosome condensation associated with fluorescence in situ hybridisation detects cytogenetic abnormalities after a CT scan: evaluaton of the low-dose effect. Radiat. Prot. Dosimetry 2003, 103:35-40.
77. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
78. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
79. Goytisolo F.A., Samper E., Martín-Caballero J., Finnon P., Herrera E., Flores J.M., et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 2000, 192:1625-1636.
80. McIlrath J., Bouffler S.D., Samper E., Cuthbert A., Wojcik A., Szumiel I., et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 2001, 61:912-915.
81. Williams E.S., Klingler R., Ponnaiya B., Hardt T., Schrock E., Lees-Miller S.P., et al. Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence. Cancer Res. 2009, 69:2100-2107.
82. Callén E., Surrallés J. Telomere dysfunction in genome instability syndromes. Mutat. Res. 2004, 567:85-104.
83. Sabatier L., Dutrillaux B., Martin M.B. Chromosomal instability. Nature 1992, 357:548.
84. Sabatier L., Lebeau J., Dutrillaux B. Chromosomal instability and alterations of telomeric repeats in irradiated human fibroblasts. Int. J. Radiat. Biol. 1994, 66:611-613.
85. Ayouaz A., Raynaud C., Heride C., Revaud D., Sabatier L. Telomeres: hallmarks of radiosensitivity. Biochimie 2008, 90:60-72.
86. Martins M.B., Sabatier L., Ricoul M., Pinton A., Dutrillaux B. Specific chromosome instability induced by heavy ions: a step towards transformation of human fibroblasts?. Mutat. Res. 1993, 285:229-237.
87. Castella M., Puerto S., Creus A., Marcos R., Surralles J. Telomere length modulates human radiation sensitivity in vitro. Toxicol. Lett. 2007, 172:29-36.
88. Berardinelli F., Antoccia A., Cherubini R., De Nadal V., Gerardi S., Tanzarella C., et al. Telomere alterations and genomic instability in long-term cultures of normal human fibroblasts irradiated with X rays and protons. Radiat. Prot. Dosimetry 2011, 143:274-278.
89. Canela A., Vera E., Klatt P., Blasco M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5300-5305.
90. Baerlocher G.M., Vulto I., de Jong G., Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 2006, 1:2365-2376.
91. Aviv A., Hunt S.C., Lin J., Cao X., Kimura M., Blackburn E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res. 2011, 39:e134.
92. Willems P., August L., Slabbert J., Romm H., Oestreicher U., Thierens H., et al. Automated micronucleus (MN) scoring for population triage in case of large scale radiation events. Int. J. Radiat. Biol. 2010, 86:2-11.
93. Rossnerova A., Spatova M., Schunck C., Sram R.J. Automated scoring of lymphocyte micronuclei by the MetaSystems Metafer image cytometry system and its application in studies of human mutagen sensitivity and biodosimetry of genotoxin exposure. Mutagenesis 2011, 26:169-175.
94. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2007, 2:1084-1104.
95. El-Zein R., Vral A., Etzel C.J. Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 2011, 26:101-106.
96. Surowy H., Rinckleb A., Luedeke M., Stuber M., Wecker A., Varga D., et al. Heritability of baseline and induced micronucleus frequencies. Mutagenesis 2011, 26:111-117.
97. Vral A., Fenech M., Thierens H. The micronucleus assay as a biological dosimeter of in vivo ionising radiation exposure. Mutagenesis 2011, 26:11-17.
98. Baeyens A., Swanson R., Herd O., Ainsbury E., Mabhengu T., Willem P., et al. A semi-automated micronucleus-centromere assay to assess low-dose radiation exposure in human lymphocytes. Int. J. Radiat. Biol. 2011, 87:923-931.
99. Abramsson-Zetterberg L., Zetterberg G., Bergqvist M., Grawé J. Human cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in transferrin-positive immature peripheral blood reticulocytes. Environ. Mol. Mutagen. 2000, 36:22-31.
100. Stopper H., Hempel K., Reiners C., Vershenya S., Lorenz R., Vukicevic V., et al. Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring. Toxicol. Lett. 2005, 156:351-360.
101. Charles M. UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Comittee on the effects of atomic radiation. J. Radiol. Prot. 2001, 21:83-86.
102. Cadet J., Douki T., Ravanat J.-L. Measurement of oxidatively generated base damage in cellular DNA. Mutat. Res. 2011, 711:3-12.
103. Eguchi K., Inada T., Yaguchi M., Satoh S., Kaneko I. Induction and repair of DNA lesions in cultured human melanoma cells exposed to a nitrogen-ion beam. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1987, 52:115-123.
104. Heilmann J., Rink H., Taucher-Scholz G., Kraft G. DNA strand break induction and rejoining and cellular recovery in mammalian cells after heavy-ion irradiation. Radiat. Res. 1993, 135:46-55.
105. Bryant P.E., Warring R., Ahnström G. DNA repair kinetics after low doses of X-rays. A comparison of results obtained by the unwinding and nucleoid sedimentation methods. Mutat. Res. 1984, 131:19-26.
106. Schwachöfer J.H., Crooijmans R.P., Hoogenhout H., Kal H.B., Schaapveld R.Q., Wessels J. Differences in repair of radiation induced damage in two human tumor cell lines as measured by cell survival and alkaline DNA unwinding. Strahlenther Onkol. 1991, 167:35-40.
107. Blöcher D. DNA double strand breaks in Ehrlich ascites tumour cells at low doses of x-rays. I. Determination of induced breaks by centrifugation at reduced speed. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1982, 42:317-328.
108. Ritter M.A., Cleaver J.E., Tobias C.A. High-LET radiations induce a large proportion of non-rejoining DNA breaks. Nature 1977, 266:653-655.
109. Yamada K., Kameyama Y., Inoue S. An improved method of alkaline sucrose density gradient sedimentation to detect less than one lesion per 1 Mb DNA. Mutat. Res. 1996, 364:125-131.
110. Dahm-Daphi J., Dikomey E. Rejoining of DNA double-strand breaks in X-irradiated CHO cells studied by constant- and graded-field gel electrophoresis. Int. J. Radiat. Biol. 1996, 69:615-621.
111. Frankenberg D., Brede H.J., Schrewe U.J., Steinmetz C., Frankenberg-Schwager M., Kasten G., et al. Induction of DNA double-strand breaks by 1H and 4He lons in primary human skin fibroblasts in the LET range of 8 to 124 keV/microm. Radiat. Res. 1999, 151:540-549.
112. Garwood D.P., Thompson L.L., Dewey W.C. Use of pulsed-field gel electrophoresis to measure X-ray-induced double-strand breaks in DNA substituted with BrdU. Radiat. Res. 1991, 128:210-215.
113. Weber K.J., Flentje M. Lethality of heavy ion-induced DNA double-strand breaks in mammalian cells. Int. J. Radiat. Biol. 1993, 64:169-178.
114. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
115. Gomolka M., Rössler U., Hornhardt S., Walsh L., Panzer W., Schmid E. Measurement of the initial levels of DNA damage in human lymphocytes induced by 29kV X rays (mammography X rays) relative to 220kV X rays and gamma rays. Radiat. Res. 2005, 163:510-519.
116. Collins A.R. The comet assay. Principles, applications, and limitations. Methods Mol. Biol. 2002, 203:163-177.
117. Olive P.L. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int. J. Radiat. Biol. 1999, 75:395-405.
118. Olive P.L. The comet assay. An overview of techniques. Methods Mol. Biol. 2002, 203:179-194.
119. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
120. Rosenberger A., Rössler U., Hornhardt S., Sauter W., Bickeböller H., Wichmann H.-E., et al. Validation of a fully automated COMET assay: 1.75 million single cells measured over a 5 year period. DNA Repair (Amst.) 2011, 10:322-337.
121. Bergqvist M., Brattström D., Stålberg M., Vaghef H., Brodin O., Hellman B. Evaluation of radiation-induced DNA damage and DNA repair in human lung cancer cell lines with different radiosensitivity using alkaline and neutral single cell gel electrophoresis. Cancer Lett. 1998, 133:9-18.
122. Lassmann M., Hänscheid H., Gassen D., Biko J., Meineke V., Reiners C., et al. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer. J. Nucl. Med. 2010, 51:1318-1325.
123. Kuefner M.A., Grudzenski S., Schwab S.A., Wiederseiner M., Heckmann M., Bautz W., et al. DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures. Invest. Radiol. 2009, 44:440-446.
124. Löbrich M., Rief N., Kühne M., Heckmann M., Fleckenstein J., Rübe C., et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8984-8989.
125. Rothkamm K., Balroop S., Shekhdar J., Fernie P., Goh V. Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. Radiology 2007, 242:244-251.
126. Beels L., Bacher K., De Wolf D., Werbrouck J., Thierens H. gamma-H2AX foci as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: are we underestimating radiation risks?. Circulation 2009, 120:1903-1909.
127. Grudzenski S., Raths A., Conrad S., Rübe C.E., Löbrich M. Inducible response required for repair of low-dose radiation damage in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14205-14210.
128. Rothkamm K., Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5057-5062.
129. Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., et al. gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle 2010, 9:662-669.
130. Hou Y.-N., Lavaf A., Huang D., Peters S., Huq R., Friedrich V., et al. Development of an automated gamma-H2AX immunocytochemistry assay. Radiat. Res. 2009, 171:360-367.
131. Turner H.C., Brenner D.J., Chen Y., Bertucci A., Zhang J., Wang H., et al. Adapting the (-H2AX assay for automated processing in human lymphocytes. 1. Technological aspects. Radiat. Res. 2011, 175:282-290.
132. Avondoglio D., Scott T., Kil W.J., Sproull M., Tofilon P.J., Camphausen K. High throughput evaluation of gamma-H2AX. Radiat. Oncol. 2009, 4:31.
133. Redon C.E., Nakamura A.J., Gouliaeva K., Rahman A., Blakely W.F., Bonner W.M. The use of gamma-H2AX as a biodosimeter for total-body radiation exposure in non-human primates. PLoS ONE 2010, 5:e15544.
134. Fong P.C., Boss D.S., Yap T.A., Tutt A., Wu P., Mergui-Roelvink M., et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 2009, 361:123-134.
135. Haghdoost S., Czene S., Näslund I., Skog S., Harms-Ringdahl M. Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro. Free Radic. Res. 2005, 39:153-162.
136. Sangsuwan T., Haghdoost S. The nucleotide pool, a target for low-dose gamma-ray-induced oxidative stress. Radiat. Res. 2008, 170:776-783.
137. Haghdoost S., Sjölander L., Czene S., Harms-Ringdahl M. The nucleotide pool is a significant target for oxidative stress. Free Radic. Biol. Med. 2006, 41:620-626.
138. Haghdoost S., Maruyama Y., Pecoits-Filho R., Heimburger O., Seeberger A., Anderstam B., et al. Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?. Antioxid. Redox Signal. 2006, 8:2169-2173.
139. Haghdoost S., Svoboda P., Näslund I., Harms-Ringdahl M., Tilikides A., Skog S. Can 8-oxo-dG be used as a predictor for individual radiosensitivity?. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50:405-410.
140. Sotiropoulou P.A., Candi A., Mascré G., De Clercq S., Youssef K.K., Lapouge G., et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat. Cell Biol. 2010, 12:572-582.
141. Alsner J., Andreassen C.N., Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin. Radiat. Oncol. 2008, 18:126-135.
142. Barnett G.C., West C.M.L., Dunning A.M., Elliott R.M., Coles C.E., Pharoah P.D.P., et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat. Rev. Cancer 2009, 9:134-142.
143. Andreassen C.N. Searching for genetic determinants of normal tissue radiosensitivity-are we on the right track?. Radiother. Oncol. 2010, 97:1-8.
144. West C., Rosenstein B.S., Alsner J., Azria D., Barnett G., Begg A., et al. Establishment of a radiogenomics consortium. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1295-1296.
145. Shlien A., Malkin D. Copy number variations and cancer susceptibility. Curr. Opin. Oncol. 2010, 22:55-63.
146. Kabacik S., Ortega-Molina A., Efeyan A., Finnon P., Bouffler S., Serrano M., et al. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity. Cell Cycle 2011, 10.
147. Liu Z., Liu D., Bojdani E., El-Naggar A.K., Vasko V., Xing M. IQGAP1 plays an important role in the invasiveness of thyroid cancer. Clin. Cancer Res. 2010, 16:6009-6018.
148. Hess J., Thomas G., Braselmann H., Bauer V., Bogdanova T., Wienberg J., et al. Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9595-9600.
149. Yuan J., Yeasky T.M., Rhee M.C., Glazer P.M. Frequent T:A-->G:C transversions in X-irradiated mouse cells. Carcinogenesis 1995, 16:83-88.
150. Gonin-Laurent N., Gibaud A., Huygue M., Lefèvre S.H., Le Bras M., Chauveinc L., et al. Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis 2006, 27:1266-1272.
151. Bigbee W.L., Fuscoe J.C., Grant S.G., Jones I.M., Gorvad A.E., Harrington-Brock K., et al. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies. Mutat. Res. 1998, 397:119-136.
152. de M.M.P., Pinto L., Santos N.F.G., Amaral A. Current status of biodosimetry based on standard cytogenetic methods. Radiat. Environ. Biophys. 2010, 49:567-581.
153. Thomas C.B., Nelson D.O., Pleshanov P., Jones I.M. Induction and decline of HPRT mutants and deletions following a low dose radiation exposure at Chernobyl. Mutat. Res. 2002, 499:177-187.
154. Varès G., Wang B., Tanaka K., Kakimoto A., Eguchi-Kasai K., Nenoi M. Mutagenic adaptive response to high-LET radiation in human lymphoblastoid cells exposed to low doses of heavy-ion radiation. Mutat. Res. 2011, 712:49-54.
155. Varès G., Wang B., Tanaka K., Kakimoto A., Eguchi-Kasai K., Nenoi M. Mutagenic adaptive response to high-LET radiation in human lymphoblastoid cells exposed to X-rays. Mutat. Res. 2011, 706:46-52.
156. Rieger K.E., Hong W.-J., Tusher V.G., Tang J., Tibshirani R., Chu G. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6635-6640.
157. Svensson J.P., Stalpers L.J.A., Esveldt-van Lange R.E.E., Franken N.A.P., Haveman J., Klein B., et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med. 2006, 3:e422.
158. Badie C., Dziwura S., Raffy C., Tsigani T., Alsbeih G., Moody J., et al. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br. J. Cancer 2008, 98:1845-1851.
159. Manning G., Kabacik S., Finnon P., Paillier F., Bouffler S., Badie C. Assessing a new gene expression analysis technique for radiation biodosimetry applications. Radiat. Measur. 2011, 46:1014-1018.
160. Kabacik S., Mackay A., Tamber N., Manning G., Finnon P., Paillier F., et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int. J. Radiat. Biol. 2011, 87:115-129.
161. Amundson S.A., Do K.T., Shahab S., Bittner M., Meltzer P., Trent J., et al. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat. Res. 2000, 154:342-346.
162. Kang C.-M., Park K.-P., Song J.-E., Jeoung D.-I., Cho C.-K., Kim T.-H., et al. Possible biomarkers for ionizing radiation exposure in human peripheral blood lymphocytes. Radiat. Res. 2003, 159:312-319.
163. Mori M., Benotmane M.A., Vanhove D., van Hummelen P., Hooghe-Peters E.L., Desaintes C. Effect of ionizing radiation on gene expression in CD4+ T lymphocytes and in Jurkat cells: unraveling novel pathways in radiation response. Cell. Mol. Life Sci. 2004, 61:1955-1964.
164. Paul S., Amundson S.A. Development of gene expression signatures for practical radiation biodosimetry. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71:1236-1244.
165. Brengues M., Paap B., Bittner M., Amundson S., Seligmann B., Korn R., et al. Biodosimetry on small blood volume using gene expression assay. Health Phys. 2010, 98:179-185.
166. Chaudhry M.A. Biomarkers for human radiation exposure. J. Biomed. Sci. 2008, 15:557-563.
167. Dressman H.K., Muramoto G.G., Chao N.J., Meadows S., Marshall D., Ginsburg G.S., et al. Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med. 2007, 4:e106.
168. Meadows S.K., Dressman H.K., Muramoto G.G., Himburg H., Salter A., Wei Z., et al. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS ONE 2008, 3:e1912.
169. Paul S., Barker C.A., Turner H.C., McLane A., Wolden S.L., Amundson S.A. Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures. Radiat. Res. 2011, 175:257-265.
170. Ory C., Ugolin N., Levalois C., Lacroix L., Caillou B., Bidart J.-M., et al. Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr. Relat. Cancer 2011, 18:193-206.
171. Hadj-Hamou N.-S., Ugolin N., Ory C., Britzen-Laurent N., Sastre-Garau X., Chevillard S., et al. A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas. Carcinogenesis 2011, 32:929-934.
172. Tapio S., Hornhardt S., Gomolka M., Leszczynski D., Posch A., Thalhammer S., et al. Use of proteomics in radiobiological research: current state of the art. Radiat. Environ. Biophys. 2010, 49:1-4.
173. Guipaud O., Holler V., Buard V., Tarlet G., Royer N., Vinh J., et al. Time-course analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics 2007, 7:3992-4002.
174. Pluder F., Barjaktarovic Z., Azimzadeh O., Mörtl S., Krämer A., Steininger S., et al. Low-dose irradiation causes rapid alterations to the proteome of the human endothelial cell line EA.hy926. Radiat. Environ. Biophys. 2011, 50:155-166.
175. Tapio S., Danescu-Mayer J., Asmuss M., Posch A., Gomolka M., Hornhardt S. Combined effects of gamma radiation and arsenite on the proteome of human TK6 lymphoblastoid cells. Mutat. Res. 2005, 581:141-152.
176. Barjaktarovic Z., Schmaltz D., Shyla A., Azimzadeh O., Schulz S., Haagen J., et al. Radiation-induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to x-rays. PLoS ONE 2011, 6:e27811.
177. Azimzadeh O., Scherthan H., Sarioglu H., Barjaktarovic Z., Conrad M., Vogt A., et al. Rapid proteomic remodeling of cardiac tissue caused by total body ionizing radiation. Proteomics 2011, 11:3299-3311.
178. Marchetti F., Coleman M.A., Jones I.M., Wyrobek A.J. Candidate protein biodosimeters of human exposure to ionizing radiation. Int. J. Radiat. Biol. 2006, 82:605-639.
179. Barrett A., Jacobs A., Kohn J., Raymond J., Powles R.L. Changes in serum amylase and its isoenzymes after whole body irradiation. Br. Med. J. (Clin Res Ed). 1982, 285:170-171.
180. Balzi M., Cremonini D., Tomassi I., Becciolini A., Giannardi G., Pelù G. Radiation effects on the parotid gland of mammals. Part 2: Modifications of plasma and parotid amylase activity. Strahlentherapie 1979, 155:566-569.
181. Bertho J.M., Demarquay C., Frick J., Joubert C., Arenales S., Jacquet N., et al. Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int. J. Radiat. Biol. 2001, 77:703-712.
182. Hayashi T., Kusunoki Y., Hakoda M., Morishita Y., Kubo Y., Maki M., et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int. J. Radiat. Biol. 2003, 79:129-136.
183. Ouellet-Morin I., Danese A., Williams B., Arseneault L. Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain Behav. Immun. 2011, 25:640-646.
184. Azimzadeh O., Barjaktarovic Z., Aubele M., Calzada-Wack J., Sarioglu H., Atkinson M.J., et al. Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics. J. Proteome Res. 2010, 9:4710-4720.
185. Petricoin E.F., Liotta L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 2004, 15:24-30.
186. Whiteside T.L. Cytokines in Human Health. Introduction to Cytokines as Targets for Immunomodulation 2007, Humana Press.
187. Singh V.K., Yadav V.S. Role of cytokines and growth factors in radioprotection. Exp. Mol. Pathol. 2005, 78:156-169.
188. Kirshner J., Jobling M.F., Pajares M.J., Ravani S.A., Glick A.B., Lavin M.J., et al. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res. 2006, 66:10861-10869.
189. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Raju U., Milas L., et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem. 2005, 280:31182-31189.
190. Petit-Frère C., Capulas E., Lyon D.A., Norbury C.J., Lowe J.E., Clingen P.H., et al. Apoptosis and cytokine release induced by ionizing or ultraviolet B radiation in primary and immortalized human keratinocytes. Carcinogenesis 2000, 21:1087-1095.
191. Rodemann H.P., Blaese M.A. Responses of normal cells to ionizing radiation. Semin. Radiat. Oncol. 2007, 17:81-88.
192. Kruse J.J.C.M., Floot B.G.J., te Poele J.A.M., Russell N.S., Stewart F.A. Radiation-induced activation of TGF-beta signaling pathways in relation to vascular damage in mouse kidneys. Radiat. Res. 2009, 171:188-197.
193. Iyer R., Lehnert B.E. Alpha-particle-induced increases in the radioresistance of normal human bystander cells. Radiat. Res. 2002, 157:3-7.
194. Ojima M., Ban N., Kai M. DNA double-strand breaks induced by very low X-ray doses are largely due to bystander effects. Radiat. Res. 2008, 170:365-371.
195. Dieriks B., De Vos W.H., Derradji H., Baatout S., Van Oostveldt P. Medium-mediated DNA repair response after ionizing radiation is correlated with the increase of specific cytokines in human fibroblasts. Mutat. Res. 2010, 687:40-48.
196. Albanese J., Martens K., Karkanitsa L.V., Schreyer S.K., Dainiak N. Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp. Hematol. 2007, 35:47-54.
197. Wouters M.D., van Gent D.C., Hoeijmakers J.H.J., Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat. Res. 2011.
198. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
199. Ernst J., Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 2010, 28:817-825.
200. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
201. Pei H., Zhang L., Luo K., Qin Y., Chesi M., Fei F., et al. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 2011, 470:124-128.
202. Fnu S., Williamson E.A., De Haro L.P., Brenneman M., Wray J., Shaheen M., et al. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:540-545.
203. Gupta A., Sharma G.G., Young C.S.H., Agarwal M., Smith E.R., Paull T.T., et al. Involvement of human MOF in ATM function. Mol. Cell. Biol. 2005, 25:5292-5305.
204. Das C., Lucia M.S., Hansen K.C., Tyler J.K. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009, 459:113-117.
205. Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J., Lukas C., et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007, 131:887-900.
206. Ikura T., Tashiro S., Kakino A., Shima H., Jacob N., Amunugama R., et al. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol. Cell. Biol. 2007, 27:7028-7040.
207. Tjeertes J.V., Miller K.M., Jackson S.P. Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. Embo J. 2009, 28:1878-1889.
208. Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 2007, 131:901-914.
209. M.-R. Pan, G. Peng, W.-C. Hung, S.-Y. Lin, Monoubiquitination of H2AX regulates DNA damage response signaling, J. Biol. Chem. (2011).
210. Aypar U., Morgan W.F., Baulch J.E. Radiation-induced genomic instability: are epigenetic mechanisms the missing link?. Int. J. Radiat. Biol. 2011, 87:179-191.
211. Grønbaek K., Hother C., Jones P.A. Epigenetic changes in cancer. Apmis 2007, 115:1039-1059.
212. Kaup S., Grandjean V., Mukherjee R., Kapoor A., Keyes E., Seymour C.B., et al. Radiation-induced genomic instability is associated with DNA methylation changes in cultured human keratinocytes. Mutat. Res. 2006, 597:87-97.
213. Aypar U., Morgan W.F., Baulch J.E. Radiation-induced epigenetic alterations after low and high LET irradiations. Mutat. Res. 2011, 707:24-33.
214. Ma S., Liu X., Jiao B., Yang Y., Liu X. Low-dose radiation-induced responses: focusing on epigenetic regulation. Int. J. Radiat. Biol. 2010, 86:517-528.
215. Harris R.A., Wang T., Coarfa C., Nagarajan R.P., Hong C., Downey S.L., et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 2010, 28:1097-1105.
216. Marsit C.J., Koestler D.C., Christensen B.C., Karagas M.R., Houseman E.A., Kelsey K.T. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J. Clin. Oncol. 2011, 29:1133-1139.
217. Hu S., Ewertz M., Tufano R.P., Brait M., Carvalho A.L., Liu D., et al. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J. Clin. Endocrinol. Metab. 2006, 91:98-104.
218. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
219. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
220. Ferracin M., Veronese A., Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn. 2010, 10:297-308.
221. Templin T., Paul S., Amundson S.A., Young E.F., Barker C.A., Wolden S.L., et al. Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 2011.
222. Wang Y., Huang J.-W., Li M., Cavenee W.K., Mitchell P.S., Zhou X., et al. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol. Cancer Res. 2011.
223. Hennessy B.T., Lu Y., Gonzalez-Angulo A.M., Carey M.S., Myhre S., Ju Z., et al. A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers. Clin. Proteomics 2010, 6:129-151.
224. Frederick M.J., VanMeter A.J., Gadhikar M.A., Henderson Y.C., Yao H., Pickering C.C., et al. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am. J. Pathol. 2011, 178:548-571.
225. Yang F., Waters K.M., Miller J.H., Gritsenko M.A., Zhao R., Du X., et al. Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation. PLoS ONE 2010, 5:e14152.
226. Cadet J., Douki T., Ravanat J.-L. Oxidatively generated base damage to cellular DNA. Free Radic. Biol. Med. 2010, 49:9-21.
227. Metabolite databases, (Accessed 08.02.2012), (n.d.). http://www.nugo.org/publicitem.m%3Fkey=metabolomics%26pgid=36124%26trail=/metabolomics/36124.
228. Coy S.L., Cheema A.K., Tyburski J.B., Laiakis E.C., Collins S.P., Fornace A.J. Radiation metabolomics and its potential in biodosimetry. Int. J. Radiat. Biol. 2011.
229. Tyburski J.B., Patterson A.D., Krausz K.W., Slavík J., Fornace A.J., Gonzalez F.J., et al. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat. Res. 2008, 170:1-14.
230. Tyburski J.B., Patterson A.D., Krausz K.W., Slavík J., Fornace A.J., Gonzalez F.J., et al. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat. Res. 2009, 172:42-57.
231. Johnson C.H., Patterson A.D., Krausz K.W., Lanz C., Kang D.W., Luecke H., et al. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat. Res. 2011, 175:473-484.
232. Wolfram R.M., Palumbo B., Chehne F., Palumbo R., Budinsky A.C., Sinzinger H. (Iso) Prostaglandins in saliva indicate oxidation injury after radioiodine therapy. Rev. Esp. Med. Nucl. 2004, 23:183-188.
233. Camphausen K., Ménard C., Sproull M., Goley E., Basu S., Coleman C.N. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1536-1539.
234. Lavin M.F., Le Poidevin P., Bates P. Enhanced levels of radiation-induced G2 phase delay in ataxia telangiectasia heterozygotes. Cancer Genet. Cytogenet. 1992, 60:183-187.
235. Lavin M.F., Bennett I., Ramsay J., Gardiner R.A., Seymour G.J., Farrell A., et al. Identification of a potentially radiosensitive subgroup among patients with breast cancer. J. Natl. Cancer Inst. 1994, 86:1627-1634.
236. Hu J.J., Smith T.R., Miller M.S., Lohman K., Case L.D. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ. Mol. Mutagen. 2002, 39:208-215.
237. Iwasaki T., Robertson N., Tsigani T., Finnon P., Scott D., Levine E., et al. Lymphocyte telomere length correlates with in vitro radiosensitivity in breast cancer cases but is not predictive of acute normal tissue reactions to radiotherapy. Int. J. Radiat. Biol. 2008, 84:277-284.
238. Xing J., Spitz M.R., Lu C., Zhao H., Yang H., Wang W., et al. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1517-1522.
239. Zhao H., Spitz M.R., Tomlinson G.E., Zhang H., Minna J.D., Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 2001, 61:7819-7824.
240. Zheng Y.-L., Loffredo C.A., Alberg A.J., Yu Z., Jones R.T., Perlmutter D., et al. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res. 2005, 65:9566-9573.
241. Finnon P., Robertson N., Dziwura S., Raffy C., Zhang W., Ainsbury L., et al. Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation. Hum. Genet. 2008, 123:485-493.
242. Camplejohn R.S., Hodgson S., Carter N., Kato B.S., Spector T.D. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins. Br. J. Cancer 2006, 95:520-524.
243. Dixon A.L., Liang L., Moffatt M.F., Chen W., Heath S., Wong K.C.C., et al. A genome-wide association study of global gene expression. Nat. Genet. 2007, 39:1202-1207.
244. Camplejohn R.S., Gilchrist R., Easton D., McKenzie-Edwards E., Barnes D.M., Eccles D.M., et al. Apoptosis, ageing and cancer susceptibility. Br. J. Cancer 2003, 88:487-490.
245. Barber J.B., West C.M., Kiltie A.E., Roberts S.A., Scott D. Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy. Radiat. Res. 2000, 153:570-578.
246. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol. 1996, 40:101-109.
247. Fattibene P., Callens F. EPR dosimetry with tooth enamel: a review. Appl. Radiat. Isot. 2010, 68:2033-2116.
248. Trompier F., Bassinet C., Clairand I. Radiation accident dosimetry on plastics by EPR spectrometry. Health Phys. 2010, 98:388-394.
249. Williams B.B., Dong R., Nicolalde R.J., Matthews T.P., Gladstone D.J., Demidenko E., et al. Physically-based biodosimetry using in vivo EPR of teeth in patients undergoing total body irradiation. Int. J. Radiat. Biol. 2011, 87:766-775.
250. Brenner A.V., Tronko M.D., Hatch M., Bogdanova T.I., Oliynik V.A., Lubin J.H., et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ. Health Perspect. 2011, 119:933-939.
251. Zablotska L.B., Ron E., Rozhko A.V., Hatch M., Polyanskaya O.N., Brenner A.V., et al. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br. J. Cancer. 2011, 104:181-187.
252. Omar R.Z., Barber J.A., Smith P.G. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br. J. Cancer. 1999, 79:1288-1301.
253. I. Thierry-Chef, P. Berard, D. Bingham, E. Blanchardon, A. Birchall, R. Bull, C. Challeton-de Vathaire, C. Hurtgen, M. Puncher, T. Riddell, M. Vrijheid, E. Cardis, Approach to derive doses for case-control studies of lung cancer and leukaemia among workers internally exposed to uranium and plutonium, Proceedings of the 12th International Congress of the International Radiation Protection Association, Buenos Aires, Argentina, Oct 19-14, 2008, Available at (2009). http://www.irpa12.org.ar/fullpapers/FP2444.pdf.
254. Vasilenko E.K., Khokhryakov V.F., Miller S.C., Fix J.J., Eckerman K., Choe D.O., et al. Mayak worker dosimetry study: an overview. Health Phys. 2007, 93:190-206.
255. Zablotska L.B., Ashmore J.P., Howe G.R. Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 2004, 161:633-641.
256. Richardson D.B., Wing S. Leukemia mortality among workers at the Savannah River Site. Am. J. Epidemiol. 2007, 166:1015-1022.
257. Boice J.D., Cohen S.S., Mumma M.T., Dupree Ellis E., Eckerman K.F., Leggett R.W., et al. Mortality among radiation workers at Rocketdyne (Atomics International), 1948-1999. Radiat. Res. 2006, 166:98-115.
258. International Organization for Standardization, 2006, Radiation protection-Monitoring of workers occupationally exposed to a risk of internal contamination with radioactive material ISO 20553:2006(E)., (n.d.).
259. Pearce N., Boffetta P. General issues of study design and analysis in the use of biomarkers in cancer epidemiology. IARC Sci. Publ. 1997, 47-57.
260. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Source and Effects from Ionizing Radiation, New York, United Nations, 2008, (n.d.).
261. Taioli E., Bonassi S. Methodological issues in pooled analysis of biomarker studies. Mutat. Res. 2002, 512:85-92.
262. Deckbar D., Jeggo P.A., Löbrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Crit. Rev. Biochem. Mol. Biol. 2011, 46:271-283.
263. Guipaud O., Benderitter M. Protein biomarkers for radiation exposure: towards a proteomic approach as a new investigation tool. Ann. Ist. Super. Sanita. 2009, 45:278-286.
264. Beels L., Werbrouck J., Thierens H. Dose response and repair kinetics of gamma-H2AX foci induced by in vitro irradiation of whole blood and T-lymphocytes with X- and gamma-radiation. Int. J. Radiat. Biol. 2010, 86:760-768.